Orkla India Limited share price

NSE: ORKLAINDIA · ISIN INE16NZ01023

Key numbers

Market cap
₹ 7,616 Cr
Current price
₹ 555.95
52-week high / low
₹ 760 / 533
Stock P/E
25.9
Book value
₹ 202.2
Dividend yield
0.00%
ROCE
13.8%
ROE
10.4%
Debt to equity
0.02
Sales growth (3 yrs)
-
Profit growth (3 yrs)
-
1-year return
-

About Orkla India Limited

Orkla India Limited operates as a food company, manufactures and sells spices and convenience foods in India and internationally. It offers instant food mixes, spices, masalas and blended curry powders; ready-to-eat food products, vermicelli, confectionery, beverages, coffee; and rice products, such as Puttu Podi, Idli Podi, Dosa Podi, Pathiri Podi, Appam Podi, and other products. The company also provides spices, pickles, tea, tamarind, coconut oil, and oral care products. It sells its products through e-commerce websites and commerce platform under the MTR, Eastern, Rasoi Magic, Wok N Roll, and Laban brand names. The company was formerly known as MTR Foods Private Limited. The company was founded in 1924 and is based in Bengaluru, India. Orkla India Limited is a subsidiary of Orkla Asia Pacific Pte. Ltd.

Quarterly results

Consolidated figures in ₹ crores

Mar 2025Jun 2025Dec 2025Mar 2026Jun 2026
Sales596597636626659
Operating profit959910397113
Net profit35-577388
EPS (₹)2.57-4.805.406.40

Concall summary (2026-08-10)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

  • It's an absolute pleasure from ICICI Securities to host the Q1FY27 Earnings Call of Orkla India Ltd.
  • Hello and welcome, everyone, to the Q1 FY27 Results for Orkla India.

Growth & demand

  • We delivered a revenue growth of 11.5% supported by volume growth of 1.7%.
  • In the domestic market, net of Kerala, the NSV growth is 16% with a volume growth of 5.2%.

Margins & costs

  • Profitability has stayed healthy with an EBITDA of INR115 crores at 17.5% EBITDA margin, a sequential improvement of 150 basis points versus the last quarter.
  • From a profitability standpoint, we maintained a healthy EBITDA margin of 17.5%, demonstrating our ability to balance growth investments with disciplined cost management.

Capex & expansion

  • Excluding the impact of Project Bolt investments and the production linked incentive benefit recognized in the base period, underlying EBITDA growth was 12.7% with EBITDA margin expansion of 40 basis points.
  • When we acquired Eastern, for the first 3 years, the entrepreneur continued to run the business because it was a completely new territory for us.

Balance sheet & cash

  • So, how do we sort of leverage that that that sort of quality focus that we have and how do we intend to stand out.
  • So, we are trying to leverage the narrative in a positive way so that we can build the entire business.

Peers in Packaged Foods

Data for information only, not investment advice. Prices end of day.